Hohmann, F P <br/><br/>
LH suppression following different low doses of the GnRH antagonist ganirelix in polycystic ovary syndrome.  [electronic resource] 

 -  Journal of endocrinological investigation  Dec 2005 
 - 990-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0391-4097 
<br/><br/><label>Standard No.: </label>10.1007/BF03345337  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Androgens--metabolism<br/>Estradiol--metabolism<br/>Female<br/>Follicle Stimulating Hormone--antagonists & inhibitors<br/>Gonadotropin-Releasing Hormone--analogs & derivatives<br/>Hormone Antagonists--therapeutic use<br/>Humans<br/>Inhibins--metabolism<br/>Luteinizing Hormone--antagonists & inhibitors<br/>Neurosecretory Systems--drug effects<br/>Ovary--drug effects<br/>Ovulation--drug effects<br/>Polycystic Ovary Syndrome--diagnosis